Clinical Trial Update: Combination Therapy With Avonex and BiMonthly High Dose Intravenous Methotrexate in Multiple Sclerosis [Phase 4]

View source ↗

Summary

A Phase 4 trial update assessing combination therapy with Avonex (interferon beta-1a) and high-dose intravenous methotrexate for multiple sclerosis; the trial s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Avonex (Interferon beta-1a)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute | Conditions: Multiple Sclerosis | Phase 4 | Status: COMPLETED